Center-Authored Papers

Filters: Author is White, Darren M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2008
Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM et al..  2008.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.. Gastroenterology. 135(2):419-28. Abstract
2010
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract
Adenosine Triphosphatases
Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM et al..  2008.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.. Gastroenterology. 135(2):419-28. Abstract
Adult
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract
Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM et al..  2008.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.. Gastroenterology. 135(2):419-28. Abstract
Age Distribution
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract
Age Factors
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract
Aged
Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM et al..  2008.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.. Gastroenterology. 135(2):419-28. Abstract
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract
Aged, 80 and over
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract
Australia
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract
Canada
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract
Center-Authored Paper
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract
Colorectal Neoplasms
Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM et al..  2008.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.. Gastroenterology. 135(2):419-28. Abstract
Colorectal Neoplasms, Hereditary Nonpolyposis
Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM et al..  2008.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.. Gastroenterology. 135(2):419-28. Abstract
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract
DNA Mutational Analysis
Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM et al..  2008.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.. Gastroenterology. 135(2):419-28. Abstract
DNA Repair Enzymes
Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM et al..  2008.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.. Gastroenterology. 135(2):419-28. Abstract
DNA-Binding Proteins
Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM et al..  2008.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.. Gastroenterology. 135(2):419-28. Abstract
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract
Endometrial Neoplasms
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract
Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM et al..  2008.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.. Gastroenterology. 135(2):419-28. Abstract
Europe
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract
Female
Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM et al..  2008.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.. Gastroenterology. 135(2):419-28. Abstract
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract